UNSPSC 51131615: Fondaparinux

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J177FOW5JL. European Medicines Agency schedules Fondaparinux in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25907. Fondaparinux generally arises in the molecular formula C31H43N3NA10O49S8. The term 'fondaparinux' is a Hazardous Substances Data Bank designation. As of Q4 2014, FONDAPARINUX remains the US FDA Preferred Term for this commodity.

Fondaparinux bears US NLM identifiers UMLS ID C0701492 and NCI Concept Code C73142. SMILES: S(=O)(=O)(O)NC1C(OS(=O)(=O)O)C(OC2OC(C(OC3OC(C(O)C(O)C3NS(=O)(=O)O)COS(=O)(=O)O)C(O)C2O)C(=O)O)C(OC1OC1C(O)C(OS(=O)(=O)O)C(OC1C(=O)O)OC1C(O)C(NS(=O)(=O)O)C(OC1COS(=O)(=O)O)OC)COS(=O)(=O)O.[NA].[NA].[NA].[NA].[NA].[NA].[NA].[NA].[NA].[NA].

UNSPSC 51131615 Fondaparinux, a Commodity code, shows no recent state and local procurement activity aligned with the pharmaceutical anticoagulant specified in the code name. The single recent opportunity tagged under this code — Sourcewell RFP #061626 for Law Enforcement Equipment — is unrelated to fondaparinux procurement and does not represent legitimate buying activity under the code.

The mismatch between the code's scope and the posted opportunity signals either a classification error in the cooperative purchasing system or a data-tagging anomaly. Business development activity under this code should be placed on watch pending clarification of whether state and local agencies are actively procuring fondaparinux or other anticoagulants through formal solicitation channels; current visibility does not support a pursue decision.